Related references
Note: Only part of the references are listed.Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult
Joseph Y. S. Ting
CLINICAL TOXICOLOGY (2007)
Tuberculosis outbreak in marijuana users, Seattle, Washington, 2004
John E. Oeltmann et al.
EMERGING INFECTIOUS DISEASES (2006)
Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle
RS Niedbala et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2005)
Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg Dronabinol or of a cannabis decoction made with 20 or 60 mg Δ9-THC
A Ménétrey et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2005)
Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
RJ McKallip et al.
JOURNAL OF IMMUNOLOGY (2005)
Marijuana smoking and head and neck cancer
M Hashibe et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Evaluating the impact of hemp food consumption on workplace drug tests
G Leson et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2001)
Δ-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway
LX Zhu et al.
JOURNAL OF IMMUNOLOGY (2000)
Δ9-tetrahydrocannabinol treatment suppresses immunity and early IFN-γ, IL-12, and IL-12 receptor β2 responses to Legionella pneumophila infection
TW Klein et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
